These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 10467419)

  • 1. RalA requirement for v-Src- and v-Ras-induced tumorigenicity and overproduction of urokinase-type plasminogen activator: involvement of metalloproteases.
    Aguirre-Ghiso JA; Frankel P; Farias EF; Lu Z; Jiang H; Olsen A; Feig LA; de Kier Joffe EB; Foster DA
    Oncogene; 1999 Aug; 18(33):4718-25. PubMed ID: 10467419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of Ral GTPase in v-Src-induced phospholipase D activation.
    Jiang H; Luo JQ; Urano T; Frankel P; Lu Z; Foster DA; Feig LA
    Nature; 1995 Nov; 378(6555):409-12. PubMed ID: 7477381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RalA mediates v-Src, v-Ras, and v-Raf regulation of CD44 and fibronectin expression in NIH3T3 fibroblasts.
    Ladeda V; Frankel P; Feig LA; Foster DA; Bal de Kier Joffe E; Aguirre-Ghiso JA
    Biochem Biophys Res Commun; 2001 May; 283(4):854-61. PubMed ID: 11350063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Signaling pathways regulating the expression of proteases during tumor progression].
    de Kier Joffé EB; Mazzoni E; Aguirre Ghiso JA
    Medicina (B Aires); 2000; 60 Suppl 2():34-40. PubMed ID: 11188928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ral and Rho-dependent activation of phospholipase D in v-Raf-transformed cells.
    Frankel P; Ramos M; Flom J; Bychenok S; Joseph T; Kerkhoff E; Rapp UR; Feig LA; Foster DA
    Biochem Biophys Res Commun; 1999 Feb; 255(2):502-7. PubMed ID: 10049738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of malignant growth potentials of v-Src-transformed human gallbladder epithelial cells by adenovirus-mediated dominant negative H-Ras.
    Tokumitsu Y; Nakano S; Ueno H; Niho Y
    J Cell Physiol; 2000 May; 183(2):221-7. PubMed ID: 10737897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RalA interacts directly with the Arf-responsive, PIP2-dependent phospholipase D1.
    Luo JQ; Liu X; Hammond SM; Colley WC; Feig LA; Frohman MA; Morris AJ; Foster DA
    Biochem Biophys Res Commun; 1997 Jun; 235(3):854-9. PubMed ID: 9207251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The small-GTPase RalA activates transcription of the urokinase plasminogen activator receptor (uPAR) gene via an AP1-dependent mechanism.
    Okan E; Drewett V; Shaw PE; Jones P
    Oncogene; 2001 Apr; 20(15):1816-24. PubMed ID: 11313929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular matrix metalloproteinase inducer up-regulates the urokinase-type plasminogen activator system promoting tumor cell invasion.
    Quemener C; Gabison EE; Naïmi B; Lescaille G; Bougatef F; Podgorniak MP; Labarchède G; Lebbé C; Calvo F; Menashi S; Mourah S
    Cancer Res; 2007 Jan; 67(1):9-15. PubMed ID: 17210677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Essential role of Raf in Ras transformation and deregulation of matrix metalloproteinase expression in ovarian epithelial cells.
    Ulkü AS; Schäfer R; Der CJ
    Mol Cancer Res; 2003 Dec; 1(14):1077-88. PubMed ID: 14707291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of phospholipase D by Ras proteins mediated by its effectors Ral-GDS, PI3K and Raf-1.
    Lucas L; Penalva V; Ramírez de Molina A; Del Peso L; Lacal JC
    Int J Oncol; 2002 Sep; 21(3):477-85. PubMed ID: 12168089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibroblasts transformed by different ras oncogenes show dissimilar patterns of protease gene expression and regulation.
    Zhang JY; Schultz RM
    Cancer Res; 1992 Dec; 52(23):6682-9. PubMed ID: 1423314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transformation of epithelial Madin-Darby canine kidney cells with p60(v-src) induces expression of membrane-type 1 matrix metalloproteinase and invasiveness.
    Kadono Y; Okada Y; Namiki M; Seiki M; Sato H
    Cancer Res; 1998 May; 58(10):2240-4. PubMed ID: 9605772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrin-linked kinase regulates osteopontin-dependent MMP-2 and uPA expression to convey metastatic function in murine mammary epithelial cancer cells.
    Mi Z; Guo H; Wai PY; Gao C; Kuo PC
    Carcinogenesis; 2006 Jun; 27(6):1134-45. PubMed ID: 16474180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. R-Ras induces malignant, but not morphologic, transformation of NIH3T3 cells.
    Cox AD; Brtva TR; Lowe DG; Der CJ
    Oncogene; 1994 Nov; 9(11):3281-8. PubMed ID: 7936652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytoskeletal reorganization leads to induction of the urokinase-type plasminogen activator gene by activating FAK and Src and subsequently the Ras/Erk signaling pathway.
    Irigoyen JP; Nagamine Y
    Biochem Biophys Res Commun; 1999 Sep; 262(3):666-70. PubMed ID: 10471383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different metastatic potentials of ras- and src-transformed BALB/c 3T3 A31 variant cells.
    Tatsuka M; Ota T; Yamagishi N; Kashihara Y; Wada M; Matsuda N; Mitsui H; Seiki M; Odashima S
    Mol Carcinog; 1996 Apr; 15(4):300-8. PubMed ID: 8634088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Negative regulation of urokinase-type plasminogen activator production through FGF-2-mediated activation of phosphoinositide 3-kinase.
    Mochizuki Y; Tsuda S; Kanetake H; Kanda S
    Oncogene; 2002 Oct; 21(46):7027-33. PubMed ID: 12370824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protease activity of urokinase and tumor progression in a syngeneic mammary cancer model.
    Merchan JR; Tang J; Hu G; Lin Y; Mutter W; Tong C; Karumanchi SA; Russell SJ; Sukhatme VP
    J Natl Cancer Inst; 2006 Jun; 98(11):756-64. PubMed ID: 16757700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of multiple matrix metalloproteinases and urokinase type plasminogen activator in cultured Kaposi sarcoma cells.
    Meade-Tollin LC; Way D; Witte MH
    Acta Histochem; 1999 Jul; 101(3):305-16. PubMed ID: 10443293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.